RRoche Read More Roche–Hansoh ADC deal: $400M upfront, $15B+ milestones2026-10-20 Roche Towers in Basel, Switzerland. [Adobe Stock] Roche is expanding a string of deals with Chinese drugmakers, committing…
NNovartis Read More Novartis pays $575 million upfront for Abogen’s mRNA autoimmune therapy in deal worth up to $7.8 billion — BigGo Finance2026-10-02 A Chinese biotech firm has landed one of the largest licensing deals ever struck for an mRNA-based therapy,…
UUBS Read More AstraZeneca’s $2 billion Summit stake wins backing from UBS and Jefferies2026-09-29 AstraZeneca’s $2 billion Summit stake wins backing from UBS and Jefferies Proactive uses images sourced from Shutterstock AstraZeneca…
UUBS Read More AstraZeneca’s $2 billion Summit stake wins backing from UBS and Jefferies2026-09-29 AstraZeneca’s $2 billion Summit stake wins backing from UBS and Jefferies Proactive uses images sourced from Shutterstock AstraZeneca…
UUBS Read More AstraZeneca shares oversold after trial flops and merger talk, says UBS2026-09-22 AstraZeneca shares oversold after trial flops and merger talk, says UBS Proactive uses images sourced from Shutterstock UBS…
UUBS Read More AstraZeneca shares oversold after trial flops and merger talk, says UBS2026-09-16 AstraZeneca shares oversold after trial flops and merger talk, says UBS Proactive uses images sourced from Shutterstock UBS…
NNovartis Read More Novartis Erases $40B in a Week, and the Lp(a) Race Now Has One Question: Antisense or siRNA? — BigGo Finance2026-09-15 Novartis entered September 2026 as one of the best-performing large-cap pharma companies on the planet — “one of…
NNovartis Read More FDA Halts SK Biopharm’s OPCALIM; Novartis’ $12 Billion Drug Fails Phase 3 — BigGo Finance2026-09-11 The partial clinical hold imposed by the U.S. Food and Drug Administration (FDA) on OPCALIM (BHV-7000), an epilepsy…
NNovartis Read More Neil Jones and Phil Masterson: The Charity Model Behind a $1.5B Novartis Deal — BigGo Finance2026-09-04 The news that Novartis agreed to pay up to $1.5 billion for a little-known British biotech called MyRix…
RRoche Read More Roche tops cancer reputation rankings as AstraZeneca climbs back2026-08-19 AstraZeneca has impressed oncology patient groups, rising to second place on PatientView’s corporate reputation ranking on the back…
GGlencore Read More British Business Headlines: GSK Investment, Burberry Stake, AstraZeneca Challenges, Glencore Allegations, Football Deal Talks2026-07-29 In a significant economic development, pharma giant GSK announced plans to establish a global research and development headquarters…
NNovartis Read More Novartis Earnings Preview: Can New Medicines Offset Generic Pressure and Growing U.S. Pricing Risks?2026-07-20 Novartis’ shift toward high-innovation pharmaceuticals has made regulatory milestones, late-stage trial results, and new product rollouts top priorities…